Literature DB >> 14765872

Treatment of unstable trochanteric fractures. Randomised comparison of the gamma nail and the proximal femoral nail.

I B Schipper1, E W Steyerberg, R M Castelein, F H W M van der Heijden, P T den Hoed, A J H Kerver, A B van Vugt.   

Abstract

The proximal femoral nail (PFN) is a recently introduced intramedullary system, designed to improve treatment of unstable trochanteric fractures of the hip. In a multicentre prospective clinical study, the intra-operative use, complications and outcome of treatment using the PFN (n = 211) were compared with those using the gamma nail (GN) (n = 213). The intra-operative blood loss was lower with the PFN (220 ml v 287 ml, p = 0.001). Post-operatively, more lateral protrusion of the hip screws of the PFN (7.6%) was documented, compared with the gamma nail (1.6%, p = 0.02). Most local complications were related to suboptimal reduction of the fracture and/or positioning of the implant. Functional outcome and consolidation were equal for both implants. Generally, the results of treatment of unstable trochanteric fractures were comparable for the PFN and GN. The pitfalls and complications were similar, and mainly surgeon- or fracture-related, rather than implant-related.

Entities:  

Mesh:

Year:  2004        PMID: 14765872

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  55 in total

1.  [Treatment results after cemented hemiprosthesis for care of unstable pertrochanteric femoral fractures in the elderly].

Authors:  S Grote; F Stegmeyer; V Bogner; P Biberthaler; W Mutschler
Journal:  Unfallchirurg       Date:  2012-03       Impact factor: 1.000

2.  Are short femoral nails superior to the sliding hip screw? A meta-analysis of 24 studies involving 3,279 fractures.

Authors:  Henry Wynn Jones; Philip Johnston; Martyn Parker
Journal:  Int Orthop       Date:  2006-02-22       Impact factor: 3.075

Review 3.  Reduction techniques for difficult subtrochanteric fractures.

Authors:  Zinon T Kokkalis; Andreas F Mavrogenis; Dimitris I Ntourantonis; Vasilios G Igoumenou; Thekla Antoniadou; Renos Karamanis; Panayiotis D Megaloikonomos; Georgios N Panagopoulos; Dimitrios Giannoulis; Eleftheria Souliotis; Theodosis Saranteas; Panayiotis J Papagelopoulos; Elias Panagiotopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-05-31

4.  A comparison of two fixation methods for femoral trochanteric fractures: a new generation intramedullary system vs sliding hip screw.

Authors:  Christian Carulli; Federico Piacentini; Tommaso Paoli; Roberto Civinini; Massimo Innocenti
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

5.  Which implant is better for treating reverse obliquity fractures of the proximal femur: a standard or long nail?

Authors:  Güvenir Okcu; Nadir Ozkayin; Cemil Okta; Ismet Topcu; Kemal Aktuglu
Journal:  Clin Orthop Relat Res       Date:  2013-09       Impact factor: 4.176

6.  Early Complications in Proximal Femoral Nailing Done for Treatment of Subtrochanteric Fractures

Authors:  B Kanthimathi; Vl Narayanan
Journal:  Malays Orthop J       Date:  2012-03

7.  3066 consecutive Gamma Nails. 12 years experience at a single centre.

Authors:  Alicja J Bojan; Claudia Beimel; Andreas Speitling; Gilbert Taglang; Carl Ekholm; Anders Jönsson
Journal:  BMC Musculoskelet Disord       Date:  2010-06-26       Impact factor: 2.362

Review 8.  Intertrochanteric fractures: a review of fixation methods.

Authors:  Senthil Nathan Sambandam; Jayadev Chandrasekharan; Varatharaj Mounasamy; Cyril Mauffrey
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-03-30

9.  Distal unlocked proximal femoral intramedullary nailing for intertrochanteric femur fractures.

Authors:  Korhan Ozkan; Koray Unay; Can Demircay; Mustafa Cakir; Engin Eceviz
Journal:  Int Orthop       Date:  2008-10-28       Impact factor: 3.075

10.  Is distal locking with IMHN necessary in every pertrochanteric fracture?

Authors:  Jirí Skála-Rosenbaum; Jan Bartonícek; Radek Bartoska
Journal:  Int Orthop       Date:  2009-11-01       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.